Literature DB >> 4736306

Clinical studies of multiple sclerosis in Japan. I. A current appraisal of 83 cases.

Y Kuroiwa, H Shibasaki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4736306     DOI: 10.1212/wnl.23.6.609

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  Comparative epidemiological studies of multiple sclerosis in South Africa and Japan.

Authors:  A V Bird; E Satoyoshi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-09       Impact factor: 10.154

2.  Roles of Treg/Th17 Cell Imbalance and Neuronal Damage in the Visual Dysfunction Observed in Experimental Autoimmune Optic Neuritis Chronologically.

Authors:  Yuanyuan Liu; Caiyun You; Zhuhong Zhang; Jingkai Zhang; Hua Yan
Journal:  Neuromolecular Med       Date:  2015-08-30       Impact factor: 3.843

3.  Cortical deafness in multiple sclerosis.

Authors:  T Tabira; S Tsuji; T Nagashima; T Nakajima; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

4.  Multiple sclerosis in Coloured South Africans.

Authors:  F R Ames; S Louw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

5.  A clinical comparative study of multiple sclerosis and neuro-Behçet's syndrome.

Authors:  S Motomura; T Tabira; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-03       Impact factor: 10.154

Review 6.  The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.

Authors:  Claudia F Lucchinetti; Yong Guo; Bogdan F Gh Popescu; Kazuo Fujihara; Yasuto Itoyama; Tatsuro Misu
Journal:  Brain Pathol       Date:  2014-01       Impact factor: 6.508

7.  Clinical studies of multiple sclerosis in Japan. Multiple sclerosis starting with retrobulbar neuritis.

Authors:  H Shibasaki; Y Kuroda; H Iwashita; Y Kuroiwa
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.